<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23628727</PMID>
      <DateCompleted>
        <Year>2013</Year>
        <Month>11</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0006-3002</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>1834</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2013</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Biochimica et biophysica acta</Title>
          <ISOAbbreviation>Biochim Biophys Acta</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.</ArticleTitle>
        <Pagination>
          <StartPage>2160</StartPage>
          <EndPage>2165</EndPage>
          <MedlinePgn>2160-5</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbapap.2013.04.020</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1570-9639(13)00174-X</ELocationID>
        <Abstract>
          <AbstractText>The Eph receptors and their ephrin ligands play crucial roles in a large number of cell-cell interaction events, including those associated with axon pathfinding, neuronal cell migration and vasculogenesis. They are also involved in the patterning of most tissues and overall cell positioning in the development of the vertebrate body plan. The Eph/ephrin signaling system manifests several unique features that differentiate it from other receptor tyrosine kinases, including initiation of bi-directional signaling cascades and the existence of ligand and receptor subclasses displaying promiscuous intra-subclass interactions, but very rare inter-subclass interactions. In this review we briefly discuss these features and focus on recent studies of the unique and expansive high-affinity Eph/ephrin assemblies that form at the sites of cell-cell contact and are required for Eph signaling initiation. This article is part of a Special Issue entitled: Emerging recognition and activation mechanisms of receptor tyrosine kinases.</AbstractText>
          <CopyrightInformation>Copyright © 2013 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nikolov</LastName>
            <ForeName>Dimitar B</ForeName>
            <Initials>DB</Initials>
            <AffiliationInfo>
              <Affiliation>Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Electronic address: nikolovd@mskcc.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Kai</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Himanen</LastName>
            <ForeName>Juha P</ForeName>
            <Initials>JP</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NS038486</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01NS038486</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>04</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Biochim Biophys Acta</MedlineTA>
        <NlmUniqueID>0217513</NlmUniqueID>
        <ISSNLinking>0006-3002</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036342">Ephrins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D036081">Receptors, Eph Family</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036342" MajorTopicYN="N">Ephrins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036081" MajorTopicYN="N">Receptors, Eph Family</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Eph</Keyword>
        <Keyword MajorTopicYN="N">Ephrin</Keyword>
        <Keyword MajorTopicYN="N">Kinase</Keyword>
        <Keyword MajorTopicYN="N">Receptor</Keyword>
        <Keyword MajorTopicYN="N">Signaling</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>1</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2013</Year>
          <Month>4</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>5</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>5</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23628727</ArticleId>
        <ArticleId IdType="mid">NIHMS481109</ArticleId>
        <ArticleId IdType="pmc">PMC3777820</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bbapap.2013.04.020</ArticleId>
        <ArticleId IdType="pii">S1570-9639(13)00174-X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci. 1998;21:309–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9530499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frisen J, Holmberg J, Barbacid M. Ephrins and their Eph receptors: multitalented directors of embryonic development. The EMBO journal. 1999;18:5159–5165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1171586</ArticleId>
            <ArticleId IdType="pubmed">10508149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kullander K, Klein R. Mechanisms and functions of EPH and ephrin signalling. Nat Rev Mol Cell Bio. 2002;3:475–486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12094214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lackmann M, Boyd AW. Eph, a protein family coming of age: more confusion, insight, or complexity? Sci Signal. 2008;1:re2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18413883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilkinson DG. Multiple roles of EPH receptors and ephrins in neural development, Nature reviews. Neuroscience. 2001;2:155–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11256076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature. 1996;383:722–725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8878483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H, Wilkinson DG, Pawson T, Davis S, Yancopoulos GD. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron. 1996;17:9–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8755474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Chumley MJ, Lackmann M, Li C, Barton WA, Jeffrey PD, Vearing C, Geleick D, Feldheim DA, Boyd AW, Henkemeyer M, Nikolov DB. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci. 2004;7:501–509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15107857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP. Ectodomain structures of Eph receptors. Seminars in cell &amp; developmental biology. 2012;23:35–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22044883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mancia F, Shapiro L. ADAM and Eph: how Ephrin-signaling cells become detached. Cell. 2005;123:185–187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16239135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science. 1987;238:1717–1720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2825356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science. 1994;266:816–819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7973638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noren NK, Yang NY, Silldorff M, Mutyala R, Pasquale EB. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. The Biochemical journal. 2009;422:433–442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2866036</ArticleId>
            <ArticleId IdType="pubmed">19552627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008;133:38–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18394988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, Pfaff SL. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell. 2005;121:127–139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15820684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stein E, Lane AA, Cerretti DP, Schoecklmann HO, Schroff AD, Van Etten RL, Daniel TO. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 1998;12:667–678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316584</ArticleId>
            <ArticleId IdType="pubmed">9499402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freywald A, Sharfe N, Roifman CM. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. J Biol Chem. 2002;277:3823–3828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11713248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bush JO, Soriano P. Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries. Genes Dev. 2010;24:2068–2080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2939368</ArticleId>
            <ArticleId IdType="pubmed">20844017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bush JO, Soriano P. Eph/ephrin signaling: genetic, phosphoproteomic, and transcriptomic approaches. Seminars in cell &amp; developmental biology. 2012;23:26–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3288612</ArticleId>
            <ArticleId IdType="pubmed">22040918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janes PW, Griesshaber B, Atapattu L, Nievergall E, Hii LL, Mensinga A, Chheang C, Day BW, Boyd AW, Bastiaens PI, Jorgensen C, Pawson T, Lackmann M. Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors. J Cell Biol. 2011;195:1033–1045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3241718</ArticleId>
            <ArticleId IdType="pubmed">22144690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oricchio E NG, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, Liu X, Bruno J, Heguy A, Olshen AB, Socci ND, Teruya-Feldstein J, Weis-Garcia F, Tam W, Shaknovich R, Melnick A, Himanen JP, Chaganti RSK, Wendel H-G. The Eph-Receptor A7 Is A Soluble Tumor Suppressor And Therapeutic Reagent Against Follicular Lymphoma. Cell. 2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3208379</ArticleId>
            <ArticleId IdType="pubmed">22036564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Komurov K, Padron D, Cheng T, Roth M, Rosenblatt KP, White MA. Comprehensive mapping of the human kinome to epidermal growth factor receptor signaling. J Biol Chem. 2010;285:21134–21142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2898331</ArticleId>
            <ArticleId IdType="pubmed">20421302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukai J, Yokote H, Yamanaka R, Arao T, Nishio K, Itakura T. EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Molecular cancer therapeutics. 2008;7:2768–2778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18790757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao Z, Zhang WF, Chen XM, Shang ZJ. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. Oral oncology. 2008;44:1110–1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18485799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salvucci O, de la Luz Sierra M, Martina JA, McCormick PJ, Tosato G. EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood. 2006;108:2914–2922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1895526</ArticleId>
            <ArticleId IdType="pubmed">16840724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW, Greenberg ME. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell. 2000;103:945–956.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11136979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nolt MJ, Lin Y, Hruska M, Murphy J, Sheffler-Colins SI, Kayser MS, Passer J, Bennett MV, Zukin RS, Dalva MB. EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner. J Neurosci. 2011;31:5353–5364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3147026</ArticleId>
            <ArticleId IdType="pubmed">21471370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White JM. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol. 2003;15:598–606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14519395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Molecular aspects of medicine. 2008;29:258–289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7112278</ArticleId>
            <ArticleId IdType="pubmed">18762209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science. 2000;289:1360–1365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10958785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell. 2005;123:291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16239146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janes PW, Wimmer-Kleikamp SH, Frangakis AS, Treble K, Griesshaber B, Sabet O, Grabenbauer M, Ting AY, Saftig P, Bastiaens PI, Lackmann M. Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS biology. 2009;7:e1000215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2753297</ArticleId>
            <ArticleId IdType="pubmed">19823572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yumoto N, Wakatsuki S, Kurisaki T, Hara Y, Osumi N, Frisen J, Sehara-Fujisawa A. Meltrin beta/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. PLoS One. 2008;3:e3322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2552171</ArticleId>
            <ArticleId IdType="pubmed">18830404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin KT, Sloniowski S, Ethell DW, Ethell IM. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J Biol Chem. 2008;283:28969–28979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2570862</ArticleId>
            <ArticleId IdType="pubmed">18713744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei S, Xu G, Bridges LC, Williams P, White JM, DeSimone DW. ADAM13 induces cranial neural crest by cleaving class B Ephrins and regulating Wnt signaling. Dev Cell. 2010;19:345–352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2951023</ArticleId>
            <ArticleId IdType="pubmed">20708595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solanas G, Cortina C, Sevillano M, Batlle E. Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol. 2011;13:1100–1107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21804545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer A, Zimmer M, Erdmann KS, Eulenburg V, Porthin A, Heumann R, Deutsch U, Klein R. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Molecular cell. 2002;9:725–737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11983165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, Chiarugi P. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J Biol Chem. 2005;280:34008–34018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16051609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shintani T, Ihara M, Sakuta H, Takahashi H, Watakabe I, Noda M. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Nat Neurosci. 2006;9:761–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16680165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou L, Jones EV, Murai KK. EphA signaling promotes actin-based dendritic spine remodeling through slingshot phosphatase. J Biol Chem. 2012;287:9346–9359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3308827</ArticleId>
            <ArticleId IdType="pubmed">22282498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singla N, Erdjument-Bromage H, Himanen JP, Muir TW, Nikolov DB. A semisynthetic Eph receptor tyrosine kinase provides insight into ligand-induced kinase activation. Chem Biol. 2011;18:361–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3286648</ArticleId>
            <ArticleId IdType="pubmed">21439481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nievergall E, Janes PW, Stegmayer C, Vail ME, Haj FG, Teng SW, Neel BG, Bastiaens PI, Lackmann M. PTP1B regulates Eph receptor function and trafficking. J Cell Biol. 2010;191:1189–1203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3002030</ArticleId>
            <ArticleId IdType="pubmed">21135139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Rajashankar KR, Lackmann M, Cowan CA, Henkemeyer M, Nikolov DB. Crystal structure of an Eph receptor-ephrin complex. Nature. 2001;414:933–938.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11780069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Nikolov DB. Purification, crystallization and preliminary characterization of an Eph-B2/ephrin-B2 complex, Acta crystallographica. Section D. Biological crystallography. 2002;58:533–535.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11856847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlessinger J. Signal transduction. Autoinhibition control. Science. 2003;300:750–752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12730587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hubbard SR, Miller WT. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol. 2007;19:117–123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2536775</ArticleId>
            <ArticleId IdType="pubmed">17306972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter T. Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol. 2009;21:140–146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2670436</ArticleId>
            <ArticleId IdType="pubmed">19269802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter T. Why nature chose phosphate to modify proteins, Philosophical transactions of the Royal Society of London. Series B. Biological sciences. 2012;367:2513–2516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3415839</ArticleId>
            <ArticleId IdType="pubmed">22889903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Goldgur Y, Miao H, Myshkin E, Guo H, Buck M, Nguyen M, Rajashankar KR, Wang B, Nikolov DB. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep. 2009;10:722–728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2727437</ArticleId>
            <ArticleId IdType="pubmed">19525919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chrencik JE, Brooun A, Kraus ML, Recht MI, Kolatkar AR, Han GW, Seifert JM, Widmer H, Auer M, Kuhn P. Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity. J Biol Chem. 2006;281:28185–28192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16867992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowden TA, Aricescu AR, Nettleship JE, Siebold C, Rahman-Huq N, Owens RJ, Stuart DI, Jones EY. Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling. Structure. 2009;17:1386–1397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2832735</ArticleId>
            <ArticleId IdType="pubmed">19836338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin H, Noberini R, Huan X, Shi J, Pasquale EB, Song J. Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity. J Biol Chem. 2010;285:644–654.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2804212</ArticleId>
            <ArticleId IdType="pubmed">19875447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith FM, Vearing C, Lackmann M, Treutlein H, Himanen J, Chen K, Saul A, Nikolov D, Boyd AW. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J Biol Chem. 2004;279:9522–9531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14660665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Yermekbayeva L, Janes PW, Walker JR, Xu K, Atapattu L, Rajashankar KR, Mensinga A, Lackmann M, Nikolov DB, Dhe-Paganon S. Architecture of Eph receptor clusters. Proc Natl Acad Sci U S A. 2010;107:10860–10865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2890748</ArticleId>
            <ArticleId IdType="pubmed">20505120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seiradake E, Harlos K, Sutton G, Aricescu AR, Jones EY. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat Struct Mol Biol. 2010;17:398–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3672960</ArticleId>
            <ArticleId IdType="pubmed">20228801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wimmer-Kleikamp SH, Janes PW, Squire A, Bastiaens PI, Lackmann M. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J Cell Biol. 2004;164:661–666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2172175</ArticleId>
            <ArticleId IdType="pubmed">14993233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin Y, Yamashita Y, Noda H, Okafuji T, Go MJ, Tanaka H. EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis. Neuroscience research. 2004;48:285–296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15154674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carvalho RF, Beutler M, Marler KJ, Knoll B, Becker-Barroso E, Heintzmann R, Ng T, Drescher U. Silencing of EphA3 through a cis interaction with ephrinA5. Nat Neurosci. 2006;9:322–330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16491080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kao TJ, Kania A. Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron. 2011;71:76–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21745639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egea J, Klein R. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol. 2007;17:230–238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17420126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dudanova I, Klein R. The axon's balancing act: cis- and trans-interactions between Ephs and ephrins. Neuron. 2011;71:1–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21745632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J. Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases. Advances in cancer research. 2012;114:1–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3626259</ArticleId>
            <ArticleId IdType="pubmed">22588054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao H, Wang B. EphA receptor signaling--complexity and emerging themes. Seminars in cell &amp; developmental biology. 2012;23:16–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3374974</ArticleId>
            <ArticleId IdType="pubmed">22040915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herath NI, Boyd AW. The role of Eph receptors and ephrin ligands in colorectal cancer, International journal of cancer. Journal international du cancer. 2010;126:2003–2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20039322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nievergall E, Saunders T, Lackmann M. Targeting of EPH receptor tyrosine kinases for anticancer therapy. Critical reviews in oncogenesis. 2012;17:211–232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22471709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010;10:165–180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2921274</ArticleId>
            <ArticleId IdType="pubmed">20179713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nievergall E, Lackmann M, Janes PW. Eph-dependent cell-cell adhesion and segregation in development and cancer. Cellular and molecular life sciences : CMLS. 2012;69:1813–1842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22204021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noberini R, Koolpe M, Peddibhotla S, Dahl R, Su Y, Cosford ND, Roth GP, Pasquale EB. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J Biol Chem. 2008;283:29461–29472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2570887</ArticleId>
            <ArticleId IdType="pubmed">18728010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murai KK, Nguyen LN, Koolpe M, McLennan R, Krull CE, Pasquale EB. Targeting the EphA4 receptor in the nervous system with biologically active peptides. Mol Cell Neurosci. 2003;24:1000–1011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14697664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koolpe M, Burgess R, Dail M, Pasquale EB. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem. 2005;280:17301–17311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15722342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petty A, Myshkin E, Qin H, Guo H, Miao H, Tochtrop GP, Hsieh JT, Page P, Liu L, Lindner DJ, Acharya C, MacKerell AD, Jr, Ficker E, Song J, Wang B. A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. PLoS One. 2012;7:e42120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3419725</ArticleId>
            <ArticleId IdType="pubmed">22916121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noberini R, Lamberto I, Pasquale EB. Targeting Eph receptors with peptides and small molecules: progress and challenges. Seminars in cell &amp; developmental biology. 2012;23:51–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3319464</ArticleId>
            <ArticleId IdType="pubmed">22044885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang B. Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners. Sci Signal. 2011;4:pe28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3431919</ArticleId>
            <ArticleId IdType="pubmed">21632467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vearing C, Lee FT, Wimmer-Kleikamp S, Spirkoska V, To C, Stylianou C, Spanevello M, Brechbiel M, Boyd AW, Scott AM, Lackmann M. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res. 2005;65:6745–6754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16061656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keane N, Freeman C, Swords R, Giles FJ. EPHA3 as a novel therapeutic target in the hematological malignancies. Expert review of hematology. 2012;5:325–340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22780212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flavell RR, Muir TW. Expressed protein ligation (EPL) in the study of signal transduction, ion conduction, and chromatin biology. Accounts of chemical research. 2009;42:107–116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18939858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muir TW. Semisynthesis of proteins by expressed protein ligation. Annual review of biochemistry. 2003;72:249–289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12626339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muir TW. Studying protein structure and function using semisynthesis. Biopolymers. 2008;90:743–750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18924136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hofmann RM, Muir TW. Recent advances in the application of expressed protein ligation to protein engineering. Current opinion in biotechnology. 2002;13:297–303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12323349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGinty RK, Kim J, Chatterjee C, Roeder RG, Muir TW. Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature. 2008;453:812–816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3774535</ArticleId>
            <ArticleId IdType="pubmed">18449190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singla N, Himanen JP, Muir TW, Nikolov DB. Toward the semisynthesis of multidomain transmembrane receptors: modification of Eph tyrosine kinases. Protein Sci. 2008;17:1740–1747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2548361</ArticleId>
            <ArticleId IdType="pubmed">18628240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mende F, Seitz O. 9-Fluorenylmethoxycarbonyl-based solid-phase synthesis of peptide alpha-thioesters. Angewandte Chemie. 2011;50:1232–1240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21290490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lahiri S, Brehs M, Olschewski D, Becker CF. Total chemical synthesis of an integral membrane enzyme: diacylglycerol kinase from Escherichia coli. Angewandte Chemie. 2011;50:3988–3992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21433227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharom FJ. Characterization and functional reconstitution of the multidrug transporter. Journal of bioenergetics and biomembranes. 1995;27:15–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7629046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morera FJ, Vargas G, Gonzalez C, Rosenmann E, Latorre R. Ion-channel reconstitution. Methods in molecular biology. 2007;400:571–585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17951760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yanagisawa M, Iwamoto M, Kato A, Yoshikawa K, Oiki S. Oriented reconstitution of a membrane protein in a giant unilamellar vesicle: experimental verification with the potassium channel KcsA. Journal of the American Chemical Society. 2011;133:11774–11779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21702488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pszon-Bartosz K, Hansen JS, Stibius KB, Groth JS, Emneus J, Geschke O, Helix-Nielsen C. Assessing the efficacy of vesicle fusion with planar membrane arrays using a mitochondrial porin as reporter. Biochem Biophys Res Commun. 2011;406:96–100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21295545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlson LA, Hurley JH. In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters. Proc Natl Acad Sci U S A. 2012;109:16928–16933.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3479502</ArticleId>
            <ArticleId IdType="pubmed">23027949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Y, Zorman S, Gundersen G, Xi Z, Ma L, Sirinakis G, Rothman JE, Zhang Y. Single reconstituted neuronal SNARE complexes zipper in three distinct stages. Science. 2012;337:1340–1343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3677750</ArticleId>
            <ArticleId IdType="pubmed">22903523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salaita K, Nair PM, Petit RS, Neve RM, Das D, Gray JW, Groves JT. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science. 2010;327:1380–1385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2895569</ArticleId>
            <ArticleId IdType="pubmed">20223987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baker TS, Olson NH, Fuller SD. Adding the third dimension to virus life cycles: three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs. Microbiology and molecular biology reviews : MMBR. 1999;63:862–922. table of contents.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC98980</ArticleId>
            <ArticleId IdType="pubmed">10585969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Topf M, Lasker K, Webb B, Wolfson H, Chiu W, Sali A. Protein structure fitting and refinement guided by cryo-EM density. Structure. 2008;16:295–307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2409374</ArticleId>
            <ArticleId IdType="pubmed">18275820</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
